These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17168431)

  • 1. Oral glutamine ameliorates chemotherapy-induced changes of intestinal permeability and does not interfere with the antitumor effect of chemotherapy in patients with breast cancer: a prospective randomized trial.
    Li Y; Yu Z; Liu F; Tan L; Wu B; Li J
    Tumori; 2006; 92(5):396-401. PubMed ID: 17168431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study.
    Russo F; Linsalata M; Clemente C; D'Attoma B; Orlando A; Campanella G; Giotta F; Riezzo G
    BMC Cancer; 2013 Feb; 13():56. PubMed ID: 23379680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test.
    Choi K; Lee SS; Oh SJ; Lim SY; Lim SY; Jeon WK; Oh TY; Kim JW
    Clin Nutr; 2007 Feb; 26(1):57-62. PubMed ID: 16949180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial.
    Daniele B; Perrone F; Gallo C; Pignata S; De Martino S; De Vivo R; Barletta E; Tambaro R; Abbiati R; D'Agostino L
    Gut; 2001 Jan; 48(1):28-33. PubMed ID: 11115819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal permeability in patients with chemotherapy-induced stomatitis.
    Melichar B; Kohout P; Brátová M; Solichová D; Králícková P; Zadák Z
    J Cancer Res Clin Oncol; 2001 May; 127(5):314-8. PubMed ID: 11355146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum.
    Melichar B; Hyspler R; Dragounová E; Dvorák J; Kalábová H; Tichá A
    BMC Cancer; 2007 Aug; 7():155. PubMed ID: 17688683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental assessment of chemotherapy-induced early intestinal damage in colon cancer the lactulose-mannitol permeability test.
    Sukkar SG; Schenone E; Foppiani L; Nobile MT
    Tumori; 2004; 90(5):461-3. PubMed ID: 15656329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy.
    Peterson DE; Jones JB; Petit RG
    Cancer; 2007 Jan; 109(2):322-31. PubMed ID: 17154160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protective effect of glutamine on intestinal barrier function in patients receiving chemotherapy].
    Jiang HP; Liu CA
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jan; 9(1):59-61. PubMed ID: 16437375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glutamine on change in early postoperative intestinal permeability and its relation to systemic inflammatory response.
    Quan ZF; Yang C; Li N; Li JS
    World J Gastroenterol; 2004 Jul; 10(13):1992-4. PubMed ID: 15222054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral glutamine to prevent chemotherapy induced stomatitis: a pilot study.
    Skubitz KM; Anderson PM
    J Lab Clin Med; 1996 Feb; 127(2):223-8. PubMed ID: 8636652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpression.
    Ando M; Yamauchi H; Aogi K; Shimizu S; Iwata H; Masuda N; Yamamoto N; Inoue K; Ohono S; Kuroi K; Hamano T; Sukigara T; Fujiwara Y
    Breast Cancer Res Treat; 2014 Jun; 145(2):401-9. PubMed ID: 24728578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy.
    Okuno SH; Woodhouse CO; Loprinzi CL; Sloan JA; LaVasseur BI; Clemens-Schutjer D; Swan D; Axvig C; Ebbert LP; Tirona MR; Michalak JC; Pierson N
    Am J Clin Oncol; 1999 Jun; 22(3):258-61. PubMed ID: 10362332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.
    von Minckwitz G; Kümmel S; Vogel P; Hanusch C; Eidtmann H; Hilfrich J; Gerber B; Huober J; Costa SD; Jackisch C; Loibl S; Mehta K; Kaufmann M;
    J Natl Cancer Inst; 2008 Apr; 100(8):542-51. PubMed ID: 18398097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of intestinal permeability with alanyl-glutamine in HIV patients: a randomized, double blinded, placebo-controlled clinical trial.
    Leite RD; Lima NL; Leite CA; Farhat CK; Guerrant RL; Lima AA
    Arq Gastroenterol; 2013; 50(1):56-63. PubMed ID: 23657308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of oral glutamine supplementation on the intestinal permeability and incidence of necrotizing enterocolitis/septicemia in premature neonates.
    Sevastiadou S; Malamitsi-Puchner A; Costalos C; Skouroliakou M; Briana DD; Antsaklis A; Roma-Giannikou E
    J Matern Fetal Neonatal Med; 2011 Oct; 24(10):1294-300. PubMed ID: 21463215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of the therapeutic effect and the safety of glutamine granules per os in patients with severe burns and trauma].
    Peng X; You ZY; Huang XK; Zhang CQ; He GZ; Xie WG; Quan ZF; Wang SL
    Zhonghua Shao Shang Za Zhi; 2004 Aug; 20(4):206-9. PubMed ID: 15447818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of enteral supplementation with glutamine granules on intestinal mucosal barrier function in severe burned patients.
    Peng X; Yan H; You Z; Wang P; Wang S
    Burns; 2004 Mar; 30(2):135-9. PubMed ID: 15019120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy.
    Anderson PM; Schroeder G; Skubitz KM
    Cancer; 1998 Oct; 83(7):1433-9. PubMed ID: 9762946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study.
    von Minckwitz G; Kümmel S; Vogel P; Hanusch C; Eidtmann H; Hilfrich J; Gerber B; Huober J; Costa SD; Jackisch C; Loibl S; Mehta K; Kaufmann M;
    J Natl Cancer Inst; 2008 Apr; 100(8):552-62. PubMed ID: 18398094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.